| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.829 | 0.004 | 0.906 | Spasmolytic | 0.737 0.005 DBMET02669 0.891 0.003 DBMET02670 0.833 0.004 DBMET02671 0.852 0.004 DBMET02673 0.882 0.003 DBMET02672 0.765 0.005 DBMET02674 0.906 0.003 DBMET02675 0.175 0.141 DBMET02677 0.166 0.149 DBMET02678 | DBMET02675 | |
| 0.641 | 0.016 | 0.641 | Antiobesity | 0.372 0.077 DBMET02669 0.596 0.021 DBMET02670 0.636 0.016 DBMET02671 0.603 0.02 DBMET02673 0.593 0.021 DBMET02672 0.342 0.091 DBMET02674 0.545 0.029 DBMET02675 0.204 0.203 DBMET02678 | ||
| 0.62 | 0.005 | 0.624 | Calcium channel L-type activator | 0.478 0.037 DBMET02669 0.546 0.014 DBMET02670 0.624 0.004 DBMET02671 0.61 0.005 DBMET02673 0.54 0.015 DBMET02672 0.464 0.043 DBMET02674 0.537 0.016 DBMET02675 0.352 0.116 DBMET02676 | DBMET02671 | |
| 0.616 | 0.004 | 0.62 | Bronchodilator | 0.225 0.015 DBMET02669 0.34 0.007 DBMET02670 0.62 0.004 DBMET02671 0.578 0.004 DBMET02673 0.351 0.007 DBMET02672 0.202 0.018 DBMET02674 0.416 0.005 DBMET02675 | DBMET02671 | |
| 0.625 | 0.014 | 0.625 | Toll-Like receptor agonist | 0.281 0.123 DBMET02669 0.519 0.028 DBMET02670 0.624 0.014 DBMET02671 0.595 0.018 DBMET02673 0.517 0.029 DBMET02672 0.253 0.145 DBMET02674 0.592 0.018 DBMET02675 | ||
| 0.625 | 0.015 | 0.625 | Toll-Like receptor 7 agonist | 0.262 0.137 DBMET02669 0.505 0.031 DBMET02670 0.624 0.015 DBMET02671 0.594 0.018 DBMET02673 0.503 0.031 DBMET02672 0.236 0.161 DBMET02674 0.581 0.019 DBMET02675 | ||
| 0.625 | 0.028 | 0.891 | Transcription factor NF kappa B inhibitor | 0.788 0.014 DBMET02669 0.851 0.01 DBMET02670 0.654 0.025 DBMET02671 0.655 0.025 DBMET02673 0.88 0.008 DBMET02672 0.807 0.012 DBMET02674 0.891 0.007 DBMET02675 0.468 0.049 DBMET02677 0.523 0.041 DBMET02678 | DBMET02675 | |
| 0.588 | 0.002 | 0.608 | Adrenaline agonist | 0.122 0.025 DBMET02669 0.169 0.011 DBMET02670 0.608 0.002 DBMET02671 0.54 0.002 DBMET02673 0.198 0.007 DBMET02672 0.099 0.038 DBMET02674 0.147 0.015 DBMET02675 | DBMET02671 | |
| 0.517 | 0.009 | 0.557 | Psychostimulant | 0.373 0.027 DBMET02669 0.557 0.007 DBMET02670 0.512 0.01 DBMET02671 0.531 0.009 DBMET02673 0.503 0.01 DBMET02672 0.387 0.025 DBMET02674 0.517 0.009 DBMET02675 0.139 0.127 DBMET02678 | DBMET02670 | |
| 0.526 | 0.021 | 0.649 | Histamine release inhibitor | 0.601 0.01 DBMET02669 0.635 0.008 DBMET02670 0.53 0.02 DBMET02671 0.509 0.026 DBMET02673 0.629 0.008 DBMET02672 0.577 0.012 DBMET02674 0.649 0.007 DBMET02675 0.241 0.162 DBMET02676 0.45 0.05 DBMET02677 0.452 0.049 DBMET02678 | DBMET02675 | |
| 0.516 | 0.013 | 0.777 | Vasodilator, coronary | 0.644 0.006 DBMET02669 0.777 0.004 DBMET02670 0.514 0.014 DBMET02671 0.527 0.012 DBMET02673 0.739 0.004 DBMET02672 0.657 0.005 DBMET02674 0.733 0.004 DBMET02675 0.218 0.166 DBMET02677 0.266 0.119 DBMET02678 | DBMET02670 | |
| 0.486 | 0.001 | 0.511 | Beta adrenoreceptor agonist | 0.06 0.008 DBMET02669 0.076 0.005 DBMET02670 0.511 0.001 DBMET02671 0.428 0.002 DBMET02673 0.09 0.004 DBMET02672 0.054 0.012 DBMET02674 0.067 0.006 DBMET02675 | DBMET02671 | |
| 0.486 | 0.005 | 0.486 | Antiadrenergic | 0.134 0.041 DBMET02670 0.482 0.006 DBMET02671 0.469 0.006 DBMET02673 0.124 0.044 DBMET02672 0.114 0.048 DBMET02675 | ||
| 0.479 | 0.005 | 0.479 | Adrenaline antagonist | 0.13 0.041 DBMET02670 0.476 0.006 DBMET02671 0.463 0.006 DBMET02673 0.12 0.044 DBMET02672 0.11 0.048 DBMET02675 | ||
| 0.5 | 0.027 | 0.506 | 5 Hydroxytryptamine release stimulant | 0.341 0.059 DBMET02669 0.384 0.049 DBMET02670 0.506 0.026 DBMET02671 0.38 0.05 DBMET02673 0.307 0.068 DBMET02672 0.232 0.098 DBMET02674 0.264 0.082 DBMET02675 0.28 0.076 DBMET02676 0.215 0.11 DBMET02677 0.215 0.11 DBMET02678 | DBMET02671 | |
| 0.511 | 0.047 | 0.765 | Cyclophilin D inhibitor | 0.621 0.024 DBMET02669 0.765 0.009 DBMET02670 0.518 0.045 DBMET02671 0.516 0.046 DBMET02673 0.759 0.009 DBMET02672 0.622 0.024 DBMET02674 0.74 0.01 DBMET02675 0.602 0.027 DBMET02677 0.641 0.021 DBMET02678 | DBMET02670 | |
| 0.496 | 0.034 | 0.642 | 5 Hydroxytryptamine release inhibitor | 0.448 0.052 DBMET02669 0.642 0.007 DBMET02670 0.506 0.031 DBMET02671 0.443 0.054 DBMET02673 0.549 0.019 DBMET02672 0.397 0.08 DBMET02674 0.534 0.023 DBMET02675 0.334 0.129 DBMET02676 0.44 0.056 DBMET02677 0.44 0.056 DBMET02678 | DBMET02670 | |
| 0.449 | 0.013 | 0.562 | Interleukin agonist | 0.519 0.008 DBMET02669 0.542 0.007 DBMET02670 0.436 0.014 DBMET02671 0.437 0.014 DBMET02673 0.562 0.006 DBMET02672 0.508 0.008 DBMET02674 0.521 0.008 DBMET02675 0.189 0.131 DBMET02676 0.282 0.058 DBMET02677 0.32 0.039 DBMET02678 | DBMET02672 | |
| 0.416 | 0.002 | 0.444 | Beta adrenoreceptor antagonist | 0.068 0.041 DBMET02669 0.081 0.026 DBMET02670 0.444 0.002 DBMET02671 0.421 0.002 DBMET02673 0.086 0.023 DBMET02672 0.069 0.04 DBMET02674 0.08 0.027 DBMET02675 | DBMET02671 | |
| 0.431 | 0.024 | 0.431 | Cardiotonic | 0.189 0.129 DBMET02669 0.341 0.042 DBMET02670 0.423 0.025 DBMET02671 0.431 0.024 DBMET02673 0.3 0.056 DBMET02672 0.193 0.125 DBMET02674 0.315 0.05 DBMET02675 | ||
| 0.404 | 0.014 | 0.404 | 5 Hydroxytryptamine uptake stimulant | 0.369 0.02 DBMET02671 0.369 0.021 DBMET02673 0.219 0.119 DBMET02676 | ||
| 0.385 | 0.002 | 0.416 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DBMET02669 0.058 0.026 DBMET02670 0.416 0.002 DBMET02671 0.408 0.002 DBMET02673 0.06 0.024 DBMET02672 0.051 0.035 DBMET02674 0.057 0.028 DBMET02675 | DBMET02671 | |
| 0.428 | 0.047 | 0.428 | Vasodilator, peripheral | 0.383 0.061 DBMET02669 0.363 0.068 DBMET02670 0.422 0.049 DBMET02671 0.419 0.049 DBMET02673 0.343 0.077 DBMET02672 0.374 0.064 DBMET02674 0.379 0.062 DBMET02675 | ||
| 0.388 | 0.007 | 0.388 | Anesthetic local | 0.359 0.008 DBMET02671 0.327 0.01 DBMET02673 | ||
| 0.406 | 0.048 | 0.821 | Antithrombotic | 0.676 0.009 DBMET02669 0.786 0.005 DBMET02670 0.41 0.047 DBMET02671 0.485 0.031 DBMET02673 0.774 0.005 DBMET02672 0.736 0.006 DBMET02674 0.821 0.004 DBMET02675 0.264 0.115 DBMET02676 0.678 0.009 DBMET02677 0.636 0.013 DBMET02678 | DBMET02675 | |
| 0.33 | 0.001 | 0.346 | Beta 2 adrenoreceptor agonist | 0.077 0.011 DBMET02669 0.084 0.007 DBMET02670 0.346 0.001 DBMET02671 0.304 0.001 DBMET02673 0.096 0.005 DBMET02672 0.073 0.015 DBMET02674 0.083 0.008 DBMET02675 | DBMET02671 | |
| 0.314 | 0.003 | 0.327 | Beta 3 adrenoreceptor antagonist | 0.327 0.003 DBMET02671 0.317 0.003 DBMET02673 | DBMET02671 | |
| 0.313 | 0.002 | 0.335 | Beta 1 adrenoreceptor antagonist | 0.05 0.046 DBMET02670 0.335 0.002 DBMET02671 0.309 0.002 DBMET02673 0.049 0.047 DBMET02672 | DBMET02671 | |
| 0.332 | 0.021 | 0.349 | Tyrosine 3 hydroxylase inhibitor | 0.348 0.016 DBMET02671 0.349 0.016 DBMET02673 0.257 0.061 DBMET02676 | DBMET02673 | |
| 0.304 | 0.004 | 0.361 | Phenylalanine 4-hydroxylase inhibitor | 0.304 0.004 DBMET02671 0.361 0.003 DBMET02673 0.088 0.032 DBMET02676 | DBMET02673 | |
| 0.316 | 0.019 | 0.405 | Peptidyltransferase inhibitor | 0.377 0.009 DBMET02669 0.405 0.006 DBMET02670 0.319 0.019 DBMET02671 0.321 0.018 DBMET02673 0.401 0.007 DBMET02672 0.379 0.009 DBMET02674 0.399 0.007 DBMET02675 0.191 0.111 DBMET02676 0.347 0.013 DBMET02677 0.354 0.011 DBMET02678 | DBMET02670 | |
| 0.287 | 0.002 | 0.337 | Beta 1 adrenoreceptor agonist | 0.022 0.018 DBMET02669 0.028 0.009 DBMET02670 0.337 0.002 DBMET02671 0.212 0.002 DBMET02673 0.032 0.007 DBMET02672 0.022 0.016 DBMET02675 | DBMET02671 | |
| 0.324 | 0.041 | 0.423 | Vasodilator | 0.357 0.031 DBMET02669 0.395 0.024 DBMET02670 0.333 0.038 DBMET02671 0.356 0.032 DBMET02673 0.402 0.023 DBMET02672 0.384 0.026 DBMET02674 0.423 0.019 DBMET02675 0.211 0.096 DBMET02677 0.197 0.107 DBMET02678 | DBMET02675 | |
| 0.332 | 0.052 | 0.337 | Sodium/bile acid cotransporter inhibitor | 0.263 0.115 DBMET02669 0.24 0.139 DBMET02670 0.337 0.048 DBMET02671 0.311 0.07 DBMET02673 0.286 0.092 DBMET02672 0.236 0.144 DBMET02674 0.245 0.133 DBMET02675 | DBMET02671 | |
| 0.307 | 0.027 | 0.311 | Calpain inhibitor | 0.175 0.141 DBMET02670 0.303 0.029 DBMET02671 0.311 0.026 DBMET02673 0.162 0.16 DBMET02675 | DBMET02673 | |
| 0.326 | 0.071 | 0.579 | Immunostimulant | 0.535 0.024 DBMET02669 0.578 0.019 DBMET02670 0.344 0.066 DBMET02671 0.32 0.073 DBMET02673 0.579 0.019 DBMET02672 0.53 0.025 DBMET02674 0.553 0.022 DBMET02675 0.317 0.074 DBMET02677 0.325 0.072 DBMET02678 | DBMET02672 | |
| 0.312 | 0.06 | 0.377 | Hypoxia-inducible factor 1 alpha inhibitor | 0.193 0.16 DBMET02669 0.279 0.077 DBMET02670 0.324 0.055 DBMET02671 0.334 0.051 DBMET02673 0.377 0.036 DBMET02672 0.21 0.14 DBMET02674 0.33 0.052 DBMET02675 | DBMET02672 | |
| 0.339 | 0.092 | 0.339 | Calpain 2 inhibitor | 0.324 0.1 DBMET02671 0.312 0.107 DBMET02673 | ||
| 0.283 | 0.036 | 0.287 | Growth hormone agonist | 0.161 0.079 DBMET02669 0.128 0.11 DBMET02670 0.287 0.035 DBMET02671 0.215 0.053 DBMET02673 0.145 0.091 DBMET02672 0.125 0.113 DBMET02674 | DBMET02671 | |
| 0.242 | 0.004 | 0.249 | Adenylate cyclase stimulant | 0.16 0.048 DBMET02669 0.17 0.035 DBMET02670 0.247 0.004 DBMET02671 0.249 0.004 DBMET02673 0.178 0.028 DBMET02672 0.164 0.042 DBMET02674 0.171 0.034 DBMET02675 | DBMET02673 | |
| 0.305 | 0.07 | 0.44 | Interleukin 2 agonist | 0.44 0.017 DBMET02669 0.394 0.029 DBMET02670 0.311 0.066 DBMET02671 0.278 0.091 DBMET02673 0.41 0.025 DBMET02672 0.425 0.021 DBMET02674 0.392 0.03 DBMET02675 0.242 0.128 DBMET02676 0.386 0.032 DBMET02677 0.386 0.032 DBMET02678 | DBMET02669 | |
| 0.289 | 0.062 | 0.292 | Transcription factor STAT inhibitor | 0.292 0.061 DBMET02671 0.271 0.073 DBMET02673 | DBMET02671 | |
| 0.253 | 0.033 | 0.268 | Insulin sensitizer | 0.17 0.107 DBMET02669 0.232 0.046 DBMET02670 0.25 0.034 DBMET02671 0.268 0.025 DBMET02673 0.226 0.05 DBMET02672 0.187 0.087 DBMET02674 0.216 0.058 DBMET02675 | DBMET02673 | |
| 0.211 | 0.002 | 0.251 | Beta 3 adrenoreceptor agonist | 0.251 0.002 DBMET02671 0.138 0.003 DBMET02673 | DBMET02671 | |
| 0.224 | 0.032 | 0.224 | Phospholipase A2 inhibitor | 0.179 0.055 DBMET02669 0.198 0.044 DBMET02670 0.221 0.033 DBMET02671 0.224 0.032 DBMET02673 0.182 0.053 DBMET02672 0.179 0.054 DBMET02674 0.176 0.056 DBMET02675 0.139 0.087 DBMET02676 0.125 0.109 DBMET02678 | ||
| 0.179 | 0.008 | 0.184 | Acetylcholine M3 receptor antagonist | 0.184 0.008 DBMET02671 0.103 0.017 DBMET02673 | DBMET02671 | |
| 0.281 | 0.112 | 0.281 | Calcium channel activator | 0.27 0.123 DBMET02671 0.223 0.181 DBMET02673 | ||
| 0.19 | 0.023 | 0.52 | Expectorant | 0.296 0.009 DBMET02669 0.492 0.004 DBMET02670 0.19 0.023 DBMET02671 0.199 0.02 DBMET02673 0.481 0.004 DBMET02672 0.309 0.008 DBMET02674 0.52 0.003 DBMET02675 0.114 0.055 DBMET02677 0.101 0.067 DBMET02678 | DBMET02675 | |
| 0.181 | 0.018 | 0.19 | Mucolytic | 0.139 0.039 DBMET02669 0.164 0.025 DBMET02670 0.182 0.018 DBMET02671 0.186 0.017 DBMET02673 0.175 0.021 DBMET02672 0.143 0.036 DBMET02674 0.19 0.016 DBMET02675 | DBMET02675 | |
| 0.189 | 0.027 | 0.189 | Acetylcholine muscarinic antagonist | 0.188 0.028 DBMET02671 0.147 0.046 DBMET02673 | ||
| 0.187 | 0.028 | 0.187 | Adenylate cyclase inhibitor | 0.107 0.078 DBMET02670 0.185 0.029 DBMET02671 0.184 0.029 DBMET02673 0.116 0.071 DBMET02672 0.093 0.091 DBMET02675 | ||
| 0.165 | 0.014 | 0.165 | Alpha adrenoreceptor agonist | 0.165 0.014 DBMET02671 0.163 0.014 DBMET02673 | ||
| 0.166 | 0.014 | 0.169 | Transcription factor STAT6 inhibitor | 0.169 0.013 DBMET02671 0.137 0.036 DBMET02673 0.169 0.013 DBMET02676 | DBMET02676 | |
| 0.193 | 0.045 | 0.193 | Acetylcholine M1 receptor antagonist | 0.192 0.046 DBMET02671 0.158 0.068 DBMET02673 | ||
| 0.184 | 0.037 | 0.184 | Cholinergic antagonist | 0.184 0.037 DBMET02671 0.151 0.052 DBMET02673 | ||
| 0.18 | 0.038 | 0.488 | Monophenol monooxygenase inhibitor | 0.284 0.02 DBMET02669 0.363 0.013 DBMET02670 0.213 0.03 DBMET02671 0.209 0.031 DBMET02673 0.488 0.008 DBMET02672 0.319 0.016 DBMET02674 0.481 0.008 DBMET02675 0.194 0.035 DBMET02677 0.161 0.043 DBMET02678 | DBMET02672 | |
| 0.156 | 0.017 | 0.157 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.052 DBMET02669 0.125 0.028 DBMET02670 0.157 0.017 DBMET02671 0.154 0.018 DBMET02673 0.122 0.029 DBMET02672 0.094 0.052 DBMET02674 0.12 0.03 DBMET02675 | DBMET02671 | |
| 0.173 | 0.035 | 0.173 | Proteasome inhibitor | 0.173 0.034 DBMET02671 0.16 0.041 DBMET02673 | ||
| 0.177 | 0.039 | 0.231 | Neurotrophic factor | 0.146 0.063 DBMET02669 0.147 0.062 DBMET02670 0.179 0.039 DBMET02671 0.222 0.019 DBMET02673 0.154 0.055 DBMET02672 0.181 0.037 DBMET02674 0.176 0.04 DBMET02675 0.231 0.016 DBMET02676 0.182 0.037 DBMET02677 0.165 0.047 DBMET02678 | DBMET02676 | |
| 0.182 | 0.047 | 0.193 | Neurotensin receptor agonist | 0.193 0.039 DBMET02671 0.161 0.078 DBMET02673 0.14 0.13 DBMET02676 | DBMET02671 | |
| 0.169 | 0.041 | 0.169 | Acetylcholine antagonist | 0.169 0.041 DBMET02671 0.134 0.059 DBMET02673 | ||
| 0.146 | 0.02 | 0.152 | Anabolic | 0.152 0.017 DBMET02671 0.134 0.028 DBMET02673 | DBMET02671 | |
| 0.153 | 0.03 | 0.174 | Carbonic anhydrase XV inhibitor | 0.174 0.024 DBMET02671 0.136 0.036 DBMET02673 | DBMET02671 | |
| 0.138 | 0.015 | 0.208 | Glutamate decarboxylase inhibitor | 0.155 0.012 DBMET02671 0.208 0.006 DBMET02673 | DBMET02673 | |
| 0.174 | 0.052 | 0.174 | Thiol protease inhibitor | 0.163 0.059 DBMET02671 0.166 0.057 DBMET02673 | ||
| 0.18 | 0.06 | 0.194 | Phospholipase C inhibitor | 0.16 0.088 DBMET02669 0.186 0.055 DBMET02671 0.194 0.048 DBMET02673 0.154 0.099 DBMET02672 0.172 0.071 DBMET02674 0.142 0.123 DBMET02675 0.157 0.092 DBMET02676 | DBMET02673 | |
| 0.168 | 0.048 | 0.175 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 DBMET02671 0.175 0.043 DBMET02673 0.131 0.079 DBMET02676 | DBMET02673 | |
| 0.233 | 0.114 | 0.255 | Insulysin inhibitor | 0.241 0.105 DBMET02671 0.224 0.124 DBMET02673 0.255 0.092 DBMET02676 | DBMET02676 | |
| 0.245 | 0.129 | 0.472 | Cholesterol antagonist | 0.443 0.042 DBMET02669 0.38 0.054 DBMET02670 0.247 0.127 DBMET02671 0.263 0.116 DBMET02673 0.47 0.037 DBMET02672 0.472 0.037 DBMET02674 0.429 0.044 DBMET02675 0.267 0.113 DBMET02677 0.246 0.128 DBMET02678 | DBMET02674 | |
| 0.172 | 0.058 | 0.344 | Melanin inhibitor | 0.194 0.043 DBMET02669 0.231 0.032 DBMET02670 0.188 0.047 DBMET02671 0.182 0.05 DBMET02673 0.344 0.017 DBMET02672 0.208 0.038 DBMET02674 0.288 0.023 DBMET02675 0.139 0.098 DBMET02676 0.194 0.043 DBMET02677 0.197 0.042 DBMET02678 | DBMET02672 | |
| 0.151 | 0.037 | 0.152 | Aminopeptidase B inhibitor | 0.152 0.037 DBMET02671 0.13 0.047 DBMET02673 | DBMET02671 | |
| 0.214 | 0.1 | 0.554 | Hypoglycemic | 0.453 0.02 DBMET02669 0.549 0.011 DBMET02670 0.232 0.088 DBMET02671 0.233 0.087 DBMET02673 0.554 0.011 DBMET02672 0.462 0.019 DBMET02674 0.534 0.013 DBMET02675 0.433 0.023 DBMET02677 0.466 0.019 DBMET02678 | DBMET02672 | |
| 0.122 | 0.019 | 0.124 | Aminopeptidase I inhibitor | 0.124 0.018 DBMET02671 0.11 0.023 DBMET02673 0.075 0.047 DBMET02676 | DBMET02671 | |
| 0.25 | 0.148 | 0.456 | Immunosuppressant | 0.452 0.046 DBMET02669 0.445 0.049 DBMET02670 0.251 0.147 DBMET02671 0.266 0.137 DBMET02673 0.447 0.048 DBMET02672 0.456 0.045 DBMET02674 0.445 0.048 DBMET02675 0.339 0.093 DBMET02677 0.323 0.101 DBMET02678 | DBMET02674 | |
| 0.196 | 0.095 | 0.211 | Nitric-oxide synthase stimulant | 0.206 0.079 DBMET02670 0.208 0.077 DBMET02671 0.211 0.072 DBMET02673 0.204 0.082 DBMET02672 0.203 0.084 DBMET02675 | DBMET02673 | |
| 0.159 | 0.058 | 0.525 | Hemostatic | 0.366 0.01 DBMET02669 0.511 0.004 DBMET02670 0.163 0.054 DBMET02671 0.227 0.025 DBMET02673 0.48 0.005 DBMET02672 0.448 0.005 DBMET02674 0.525 0.004 DBMET02675 0.299 0.016 DBMET02677 0.263 0.02 DBMET02678 | DBMET02675 | |
| 0.144 | 0.05 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | 0.141 0.053 DBMET02671 0.147 0.045 DBMET02673 | DBMET02673 | |
| 0.146 | 0.053 | 0.175 | Interleukin 4 antagonist | 0.157 0.044 DBMET02669 0.134 0.067 DBMET02670 0.159 0.042 DBMET02671 0.17 0.035 DBMET02673 0.155 0.045 DBMET02672 0.175 0.032 DBMET02674 0.155 0.045 DBMET02675 0.109 0.103 DBMET02677 | DBMET02674 | |
| 0.106 | 0.014 | 0.106 | Maillard reaction inhibitor | 0.049 0.045 DBMET02669 0.058 0.036 DBMET02670 0.106 0.015 DBMET02671 0.098 0.017 DBMET02673 0.083 0.023 DBMET02672 0.067 0.03 DBMET02675 | ||
| 0.124 | 0.038 | 0.143 | Sphingomyelinase inhibitor | 0.089 0.073 DBMET02669 0.1 0.06 DBMET02670 0.108 0.052 DBMET02671 0.143 0.028 DBMET02673 0.084 0.081 DBMET02672 0.104 0.055 DBMET02674 0.129 0.035 DBMET02675 | DBMET02673 | |
| 0.102 | 0.016 | 0.102 | Alpha 1 adrenoreceptor agonist | 0.097 0.018 DBMET02671 0.084 0.022 DBMET02673 | ||
| 0.114 | 0.031 | 0.117 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET02670 0.115 0.03 DBMET02671 0.117 0.028 DBMET02673 0.084 0.063 DBMET02672 | DBMET02673 | |
| 0.109 | 0.028 | 0.116 | Somatostatin 1 agonist | 0.071 0.063 DBMET02670 0.116 0.025 DBMET02671 0.101 0.033 DBMET02673 0.07 0.064 DBMET02672 | DBMET02671 | |
| 0.122 | 0.043 | 0.158 | DOPA decarboxylase inhibitor | 0.136 0.03 DBMET02671 0.136 0.03 DBMET02673 0.158 0.017 DBMET02676 | DBMET02676 | |
| 0.155 | 0.076 | 0.31 | Anticoagulant | 0.31 0.027 DBMET02669 0.275 0.033 DBMET02670 0.153 0.077 DBMET02671 0.156 0.075 DBMET02673 0.27 0.034 DBMET02672 0.308 0.027 DBMET02674 0.272 0.034 DBMET02675 0.209 0.05 DBMET02677 0.211 0.049 DBMET02678 | DBMET02669 | |
| 0.126 | 0.047 | 0.132 | Nav1.4 sodium channel blocker | 0.132 0.043 DBMET02671 0.118 0.054 DBMET02673 | DBMET02671 | |
| 0.121 | 0.043 | 0.134 | Carbonic anhydrase III inhibitor | 0.134 0.035 DBMET02671 0.113 0.05 DBMET02673 | DBMET02671 | |
| 0.126 | 0.053 | 0.126 | Alpha 2b adrenoreceptor antagonist | 0.12 0.059 DBMET02671 0.126 0.054 DBMET02673 | ||
| 0.118 | 0.049 | 0.128 | Electron transport complex I inhibitor | 0.115 0.054 DBMET02671 0.128 0.037 DBMET02673 0.097 0.09 DBMET02675 | DBMET02673 | |
| 0.088 | 0.021 | 0.088 | Plasminogen activator inhibitor | 0.086 0.022 DBMET02671 0.077 0.027 DBMET02673 | ||
| 0.077 | 0.014 | 0.082 | Epithelial sodium channel blocker | 0.053 0.041 DBMET02670 0.082 0.012 DBMET02671 0.063 0.025 DBMET02673 0.05 0.049 DBMET02672 | DBMET02671 | |
| 0.128 | 0.064 | 0.135 | Papain-like protease (SARS coronavirus) inhibitor | 0.135 0.051 DBMET02671 0.112 0.105 DBMET02673 | DBMET02671 | |
| 0.082 | 0.019 | 0.089 | NMDA 2A receptor antagonist | 0.089 0.017 DBMET02671 | DBMET02671 | |
| 0.114 | 0.053 | 0.114 | Protease inhibitor | 0.09 0.074 DBMET02669 0.091 0.074 DBMET02670 0.112 0.054 DBMET02671 0.108 0.058 DBMET02673 0.09 0.074 DBMET02672 0.085 0.08 DBMET02674 0.086 0.078 DBMET02675 | ||
| 0.125 | 0.067 | 0.206 | M18 aspartyl aminopeptidase inhibitor | 0.134 0.061 DBMET02671 0.206 0.032 DBMET02673 | DBMET02673 | |
| 0.08 | 0.026 | 0.086 | Carbonic anhydrase stimulant | 0.076 0.028 DBMET02671 0.086 0.023 DBMET02673 | DBMET02673 | |
| 0.1 | 0.048 | 0.118 | Opioid antagonist | 0.118 0.037 DBMET02671 0.093 0.053 DBMET02673 | DBMET02671 | |
| 0.106 | 0.056 | 0.106 | Factor V inhibitor | 0.104 0.061 DBMET02671 0.105 0.059 DBMET02673 | ||
| 0.085 | 0.035 | 0.109 | Opioid delta receptor antagonist | 0.109 0.028 DBMET02671 0.077 0.038 DBMET02673 | DBMET02671 | |
| 0.073 | 0.027 | 0.073 | Human rhinovirus A protease inhibitor | 0.073 0.027 DBMET02671 0.071 0.028 DBMET02673 | ||
| 0.075 | 0.029 | 0.101 | Neuraminidase inhibitor | 0.086 0.021 DBMET02669 0.094 0.018 DBMET02670 0.08 0.025 DBMET02671 0.084 0.023 DBMET02673 0.101 0.015 DBMET02672 0.094 0.018 DBMET02674 0.098 0.016 DBMET02675 | DBMET02672 | |
| 0.179 | 0.133 | 0.502 | Antioxidant | 0.408 0.034 DBMET02669 0.439 0.028 DBMET02670 0.206 0.109 DBMET02671 0.263 0.077 DBMET02673 0.479 0.023 DBMET02672 0.469 0.024 DBMET02674 0.502 0.02 DBMET02675 0.433 0.029 DBMET02677 0.46 0.025 DBMET02678 | DBMET02675 | |
| 0.164 | 0.118 | 0.235 | Neurotrophic factor enhancer | 0.173 0.107 DBMET02671 0.196 0.08 DBMET02673 0.184 0.093 DBMET02672 0.153 0.134 DBMET02674 0.213 0.065 DBMET02675 0.214 0.064 DBMET02676 0.235 0.047 DBMET02677 0.201 0.076 DBMET02678 | DBMET02677 | |
| 0.117 | 0.072 | 0.121 | Histone deacetylase class III inhibitor | 0.121 0.069 DBMET02671 0.119 0.071 DBMET02673 0.111 0.078 DBMET02676 | DBMET02671 | |
| 0.133 | 0.089 | 0.216 | Peroxidase inhibitor | 0.163 0.072 DBMET02671 0.164 0.071 DBMET02673 0.216 0.055 DBMET02676 | DBMET02676 | |
| 0.056 | 0.011 | 0.056 | Diamine oxidase inhibitor | 0.048 0.016 DBMET02671 0.043 0.02 DBMET02673 | ||
| 0.058 | 0.014 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.065 0.01 DBMET02669 0.066 0.009 DBMET02670 0.058 0.014 DBMET02671 0.057 0.015 DBMET02673 0.066 0.009 DBMET02672 0.064 0.01 DBMET02674 0.064 0.01 DBMET02675 | DBMET02672 | |
| 0.098 | 0.056 | 0.141 | Falcipain inhibitor | 0.091 0.062 DBMET02669 0.122 0.043 DBMET02670 0.098 0.056 DBMET02671 0.093 0.06 DBMET02673 0.141 0.035 DBMET02672 0.087 0.065 DBMET02674 0.123 0.043 DBMET02675 | DBMET02672 | |
| 0.073 | 0.031 | 0.11 | Neuraminidase (influenza) inhibitor | 0.092 0.019 DBMET02669 0.096 0.017 DBMET02670 0.079 0.026 DBMET02671 0.079 0.026 DBMET02673 0.11 0.014 DBMET02672 0.099 0.017 DBMET02674 0.101 0.016 DBMET02675 | DBMET02672 | |
| 0.089 | 0.049 | 0.089 | Glutathione S-transferase inhibitor | 0.086 0.053 DBMET02671 0.078 0.064 DBMET02673 | ||
| 0.055 | 0.015 | 0.055 | Plasmepsin II inhibitor | 0.05 0.018 DBMET02671 0.044 0.024 DBMET02673 | ||
| 0.158 | 0.118 | 0.593 | Angiogenesis stimulant | 0.498 0.012 DBMET02669 0.527 0.01 DBMET02670 0.176 0.107 DBMET02671 0.158 0.117 DBMET02673 0.537 0.01 DBMET02672 0.491 0.012 DBMET02674 0.518 0.011 DBMET02675 0.477 0.013 DBMET02677 0.593 0.007 DBMET02678 | DBMET02678 | |
| 0.087 | 0.048 | 0.098 | Opioid kappa receptor antagonist | 0.098 0.037 DBMET02671 0.08 0.058 DBMET02673 | DBMET02671 | |
| 0.18 | 0.142 | 0.182 | Superoxide dismutase inhibitor | 0.182 0.139 DBMET02671 0.175 0.149 DBMET02673 | DBMET02671 | |
| 0.093 | 0.057 | 0.136 | Falcipain 2 inhibitor | 0.087 0.063 DBMET02669 0.117 0.043 DBMET02670 0.093 0.057 DBMET02671 0.088 0.061 DBMET02673 0.136 0.035 DBMET02672 0.083 0.066 DBMET02674 0.119 0.043 DBMET02675 | DBMET02672 | |
| 0.077 | 0.041 | 0.097 | Opioid mu receptor antagonist | 0.097 0.033 DBMET02671 0.069 0.047 DBMET02673 | DBMET02671 | |
| 0.066 | 0.031 | 0.074 | Ribonucleoside-diphosphate reductase inhibitor | 0.074 0.027 DBMET02671 0.067 0.03 DBMET02673 | DBMET02671 | |
| 0.067 | 0.032 | 0.075 | Ribonucleotide reductase inhibitor | 0.075 0.029 DBMET02671 0.071 0.031 DBMET02673 | DBMET02671 | |
| 0.061 | 0.028 | 0.061 | Myc inhibitor | 0.061 0.028 DBMET02671 0.06 0.029 DBMET02673 | ||
| 0.06 | 0.028 | 0.063 | Urokinase inhibitor | 0.063 0.027 DBMET02669 0.057 0.029 DBMET02671 0.057 0.029 DBMET02673 0.061 0.028 DBMET02674 | DBMET02669 | |
| 0.064 | 0.032 | 0.064 | Cathepsin B inhibitor | 0.063 0.033 DBMET02671 0.06 0.036 DBMET02673 | ||
| 0.099 | 0.071 | 0.107 | Falcipain 3 inhibitor | 0.097 0.074 DBMET02671 0.107 0.064 DBMET02673 0.098 0.072 DBMET02676 | DBMET02673 | |
| 0.07 | 0.044 | 0.07 | Sirtuin 1 inhibitor | 0.07 0.045 DBMET02671 | ||
| 0.075 | 0.048 | 0.075 | Cathepsin G inhibitor | 0.074 0.049 DBMET02671 | ||
| 0.159 | 0.135 | 0.295 | Antiamyloidogenic | 0.205 0.096 DBMET02669 0.184 0.111 DBMET02670 0.174 0.119 DBMET02671 0.212 0.092 DBMET02673 0.279 0.059 DBMET02672 0.268 0.063 DBMET02674 0.295 0.053 DBMET02675 | DBMET02675 | |
| 0.074 | 0.051 | 0.074 | Glutamate dehydrogenase inhibitor | 0.071 0.055 DBMET02671 0.066 0.063 DBMET02673 | ||
| 0.062 | 0.041 | 0.062 | Purinergic P2X1 antagonist | 0.056 0.05 DBMET02671 | ||
| 0.065 | 0.044 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 DBMET02671 0.059 0.054 DBMET02673 | ||
| 0.071 | 0.05 | 0.085 | Histidine decarboxylase inhibitor | 0.085 0.039 DBMET02671 | DBMET02671 | |
| 0.026 | 0.006 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET02671 0.025 0.008 DBMET02673 | DBMET02671 | |
| 0.06 | 0.04 | 0.06 | Cathepsin E inhibitor | 0.059 0.042 DBMET02671 0.055 0.049 DBMET02673 | ||
| 0.06 | 0.041 | 0.06 | Acetylcholine M5 receptor antagonist | |||
| 0.055 | 0.038 | 0.055 | Cathepsin D inhibitor | 0.052 0.04 DBMET02671 0.05 0.041 DBMET02673 | ||
| 0.052 | 0.035 | 0.098 | Factor IXa inhibitor | 0.086 0.014 DBMET02669 0.098 0.01 DBMET02670 0.05 0.038 DBMET02671 0.097 0.01 DBMET02672 0.076 0.018 DBMET02674 0.084 0.014 DBMET02675 0.054 0.033 DBMET02677 0.054 0.033 DBMET02678 | DBMET02670 | |
| 0.129 | 0.113 | 0.273 | Interferon gamma antagonist | 0.249 0.028 DBMET02669 0.187 0.046 DBMET02670 0.136 0.099 DBMET02671 0.138 0.096 DBMET02673 0.228 0.033 DBMET02672 0.273 0.024 DBMET02674 0.247 0.029 DBMET02675 0.169 0.058 DBMET02677 0.145 0.085 DBMET02678 | DBMET02674 | |
| 0.058 | 0.042 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.039 DBMET02671 | DBMET02671 | |
| 0.101 | 0.086 | 0.108 | Cholesterol synthesis inhibitor | 0.108 0.078 DBMET02671 | DBMET02671 | |
| 0.15 | 0.136 | 0.256 | Hypolipemic | 0.183 0.107 DBMET02669 0.254 0.065 DBMET02670 0.15 0.136 DBMET02671 0.256 0.065 DBMET02672 0.174 0.115 DBMET02674 0.236 0.074 DBMET02675 0.144 0.143 DBMET02677 | DBMET02672 | |
| 0.109 | 0.096 | 0.139 | Bone formation stimulant | 0.121 0.084 DBMET02671 0.109 0.097 DBMET02673 0.109 0.096 DBMET02672 0.139 0.068 DBMET02676 0.125 0.081 DBMET02677 0.12 0.086 DBMET02678 | DBMET02676 | |
| 0.021 | 0.009 | 0.023 | Estrogen-related receptor gamma agonist | 0.023 0.007 DBMET02671 0.018 0.013 DBMET02673 0.017 0.016 DBMET02676 | DBMET02671 | |
| 0.121 | 0.109 | 0.295 | Thrombolytic | 0.237 0.037 DBMET02669 0.263 0.03 DBMET02670 0.123 0.107 DBMET02671 0.144 0.086 DBMET02673 0.265 0.03 DBMET02672 0.253 0.033 DBMET02674 0.288 0.026 DBMET02675 0.121 0.109 DBMET02676 0.284 0.027 DBMET02677 0.295 0.025 DBMET02678 | DBMET02678 | |
| 0.085 | 0.072 | 0.176 | Alcohol dehydrogenase inhibitor | 0.081 0.079 DBMET02670 0.098 0.054 DBMET02671 0.176 0.015 DBMET02676 0.151 0.02 DBMET02677 0.148 0.021 DBMET02678 | DBMET02676 | |
| 0.052 | 0.041 | 0.064 | Leukotriene B4 antagonist | 0.051 0.042 DBMET02669 0.062 0.026 DBMET02670 0.05 0.044 DBMET02671 0.064 0.023 DBMET02672 0.054 0.036 DBMET02675 | DBMET02672 | |
| 0.095 | 0.085 | 0.116 | Chelator | 0.097 0.081 DBMET02671 0.116 0.057 DBMET02673 0.094 0.086 DBMET02674 | DBMET02673 | |
| 0.03 | 0.021 | 0.03 | Plasmepsin I inhibitor | 0.029 0.022 DBMET02671 0.029 0.022 DBMET02673 | ||
| 0.079 | 0.07 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.058 DBMET02671 | DBMET02671 | |
| 0.028 | 0.02 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET02669 0.031 0.012 DBMET02670 0.03 0.015 DBMET02671 0.028 0.02 DBMET02673 0.032 0.01 DBMET02672 0.029 0.018 DBMET02674 0.031 0.012 DBMET02675 | DBMET02672 | |
| 0.098 | 0.09 | 0.103 | TRPA1 agonist | 0.103 0.083 DBMET02671 | DBMET02671 | |
| 0.129 | 0.121 | 0.138 | CF transmembrane conductance regulator agonist | 0.138 0.1 DBMET02671 | DBMET02671 | |
| 0.087 | 0.08 | 0.092 | Bile acid receptor antagonist | 0.09 0.073 DBMET02671 0.087 0.082 DBMET02673 0.092 0.068 DBMET02676 | DBMET02676 | |
| 0.053 | 0.046 | 0.055 | Kallikrein 1 inhibitor | 0.052 0.047 DBMET02671 0.055 0.041 DBMET02673 | DBMET02673 | |
| 0.051 | 0.044 | 0.052 | Angiotensin-converting enzyme inhibitor | 0.052 0.043 DBMET02671 | DBMET02671 | |
| 0.15 | 0.145 | 0.36 | Platelet antagonist | 0.36 0.036 DBMET02669 0.302 0.052 DBMET02670 0.151 0.143 DBMET02673 0.276 0.062 DBMET02672 0.359 0.036 DBMET02674 0.28 0.06 DBMET02675 0.28 0.06 DBMET02677 0.303 0.052 DBMET02678 | DBMET02669 | |
| 0.081 | 0.077 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 DBMET02673 | DBMET02673 | |
| 0.085 | 0.081 | 0.085 | Toll-Like receptor 3 antagonist | |||
| 0.064 | 0.061 | 0.065 | Secretase beta inhibitor | 0.065 0.06 DBMET02671 | DBMET02671 | |
| 0.054 | 0.051 | 0.059 | Alpha 2 adrenoreceptor agonist | 0.053 0.052 DBMET02671 0.059 0.043 DBMET02673 | DBMET02673 | |
| 0.015 | 0.013 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.014 DBMET02671 0.015 0.013 DBMET02676 | ||
| 0.02 | 0.019 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.019 DBMET02673 | ||
| 0.024 | 0.023 | 0.026 | Thyroid hormone agonist | 0.026 0.018 DBMET02671 | DBMET02671 | |
| 0.044 | 0.045 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET02671 | DBMET02671 | |
| 0.213 | 0.214 | 0.646 | Antibacterial | 0.614 0.017 DBMET02669 0.59 0.021 DBMET02670 0.229 0.197 DBMET02671 0.246 0.18 DBMET02673 0.611 0.018 DBMET02672 0.629 0.015 DBMET02674 0.625 0.016 DBMET02675 0.248 0.178 DBMET02676 0.64 0.014 DBMET02677 0.646 0.014 DBMET02678 | DBMET02678 | |
| 0.034 | 0.036 | 0.035 | Erythropoietin receptor agonist | 0.035 0.034 DBMET02671 | DBMET02671 | |
| 0.084 | 0.088 | 0.194 | Mediator release inhibitor | 0.114 0.053 DBMET02669 0.162 0.024 DBMET02670 0.09 0.082 DBMET02671 0.092 0.079 DBMET02673 0.194 0.016 DBMET02672 0.12 0.047 DBMET02674 0.187 0.017 DBMET02675 | DBMET02672 | |
| 0.091 | 0.096 | 0.181 | DNA polymerase I inhibitor | 0.149 0.05 DBMET02669 0.13 0.061 DBMET02670 0.099 0.087 DBMET02671 0.141 0.054 DBMET02673 0.127 0.063 DBMET02672 0.181 0.035 DBMET02674 0.143 0.053 DBMET02675 0.102 0.084 DBMET02676 0.123 0.066 DBMET02677 0.125 0.065 DBMET02678 | DBMET02674 | |
| 0.037 | 0.042 | 0.042 | Glycine transporter 2 inhibitor | 0.042 0.036 DBMET02671 | DBMET02671 | |
| 0.11 | 0.115 | 0.117 | Vanilloid 1 agonist | 0.117 0.095 DBMET02673 0.113 0.106 DBMET02674 | DBMET02673 | |
| 0.145 | 0.151 | 0.451 | Free radical scavenger | 0.367 0.035 DBMET02669 0.381 0.032 DBMET02670 0.174 0.12 DBMET02671 0.236 0.075 DBMET02673 0.427 0.025 DBMET02672 0.432 0.024 DBMET02674 0.451 0.022 DBMET02675 0.157 0.137 DBMET02676 0.401 0.029 DBMET02677 0.449 0.022 DBMET02678 | DBMET02675 | |
| 0.034 | 0.04 | 0.04 | Oxytocin agonist | 0.04 0.031 DBMET02671 | DBMET02671 | |
| 0.098 | 0.106 | 0.256 | Cyclooxygenase 3 inhibitor | 0.184 0.025 DBMET02669 0.253 0.009 DBMET02670 0.256 0.008 DBMET02672 0.183 0.026 DBMET02674 0.227 0.012 DBMET02675 0.159 0.041 DBMET02677 0.176 0.03 DBMET02678 | DBMET02672 | |
| 0.051 | 0.059 | 0.311 | Selectin antagonist | 0.289 0.006 DBMET02669 0.31 0.005 DBMET02670 0.066 0.045 DBMET02673 0.311 0.005 DBMET02672 0.297 0.005 DBMET02674 0.303 0.005 DBMET02675 0.276 0.007 DBMET02677 0.279 0.007 DBMET02678 | DBMET02672 | |
| 0.018 | 0.028 | 0.05 | Protein 30S ribosomal subunit inhibitor | 0.042 0.009 DBMET02669 0.049 0.008 DBMET02670 0.05 0.008 DBMET02672 0.042 0.01 DBMET02674 0.048 0.008 DBMET02675 0.041 0.01 DBMET02677 0.041 0.01 DBMET02678 | DBMET02672 | |
| 0.045 | 0.057 | 0.055 | Vanilloid 2 antagonist | 0.055 0.03 DBMET02673 | DBMET02673 | |
| 0.083 | 0.096 | 0.107 | Estrogen receptor beta antagonist | 0.107 0.052 DBMET02671 | DBMET02671 | |
| 0.016 | 0.029 | 0.043 | Aminopeptidase P inhibitor | 0.043 0.005 DBMET02676 0.024 0.015 DBMET02677 0.024 0.015 DBMET02678 | DBMET02676 | |
| 0.179 | 0.194 | 0.224 | MAP kinase kinase 3 inhibitor | 0.224 0.066 DBMET02676 | DBMET02676 | |
| 0.043 | 0.062 | 0.053 | Factor III inhibitor | 0.047 0.042 DBMET02669 0.053 0.028 DBMET02670 0.053 0.028 DBMET02672 0.048 0.041 DBMET02674 0.052 0.03 DBMET02675 0.047 0.044 DBMET02678 | DBMET02672 | |
| 0.058 | 0.083 | 0.068 | Analgesic, opioid | 0.068 0.064 DBMET02671 | DBMET02671 | |
| 0.146 | 0.171 | 0.218 | MAP kinase kinase 5 inhibitor | 0.218 0.018 DBMET02676 0.156 0.13 DBMET02677 0.156 0.13 DBMET02678 | DBMET02676 | |
| 0.014 | 0.039 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 DBMET02669 0.021 0.009 DBMET02670 0.022 0.008 DBMET02672 0.02 0.012 DBMET02674 0.019 0.012 DBMET02675 | DBMET02669 | |
| 0.08 | 0.107 | 0.099 | Cystathionine beta-synthase inhibitor | 0.092 0.087 DBMET02671 0.099 0.078 DBMET02676 0.092 0.086 DBMET02678 | DBMET02676 | |
| 0.072 | 0.1 | 0.085 | Vanilloid agonist | 0.085 0.057 DBMET02673 | DBMET02673 | |
| 0.091 | 0.121 | 0.115 | Estrogen antagonist | 0.115 0.065 DBMET02671 | DBMET02671 | |
| 0.031 | 0.061 | 0.069 | Mannosidase inhibitor | 0.055 0.02 DBMET02669 0.069 0.012 DBMET02670 0.068 0.013 DBMET02672 0.043 0.035 DBMET02674 0.055 0.021 DBMET02675 | DBMET02670 | |
| 0.094 | 0.126 | 0.168 | Sphingosine 1-phosphate receptor 2 agonist | 0.168 0.018 DBMET02676 | DBMET02676 | |
| 0.051 | 0.085 | 0.065 | Interferon inducer | 0.065 0.043 DBMET02670 0.063 0.046 DBMET02675 | DBMET02670 | |
| 0.118 | 0.154 | 0.139 | Interleukin antagonist | 0.139 0.127 DBMET02671 | DBMET02671 | |
| 0.038 | 0.076 | 0.069 | Alpha-mannosidase inhibitor | 0.058 0.029 DBMET02669 0.068 0.018 DBMET02670 0.069 0.017 DBMET02672 0.058 0.029 DBMET02675 | DBMET02672 | |
| 0.123 | 0.162 | 0.148 | P-glycoprotein inhibitor | 0.138 0.136 DBMET02672 0.148 0.121 DBMET02675 | DBMET02675 | |
| 0.04 | 0.081 | 0.061 | Dopamine agonist | 0.061 0.052 DBMET02673 | DBMET02673 | |
| 0.01 | 0.051 | 0.019 | Factor IX inhibitor | 0.019 0.012 DBMET02669 0.018 0.014 DBMET02674 | DBMET02669 | |
| 0.007 | 0.048 | 0.018 | Ileal bile acid transport inhibitor | 0.018 0.011 DBMET02670 0.018 0.011 DBMET02672 | DBMET02672 | |
| 0.057 | 0.104 | 0.079 | Interferon agonist | 0.079 0.054 DBMET02670 0.074 0.063 DBMET02675 | DBMET02670 | |
| 0.024 | 0.075 | 0.06 | Antibiotic Aminoglycoside-like | 0.055 0.011 DBMET02669 0.06 0.008 DBMET02670 0.06 0.009 DBMET02672 0.053 0.011 DBMET02674 0.058 0.009 DBMET02675 0.057 0.01 DBMET02677 0.057 0.01 DBMET02678 | DBMET02672 | |
| 0.085 | 0.136 | 0.131 | Toll-Like receptor 2 antagonist | 0.131 0.067 DBMET02673 0.107 0.094 DBMET02676 | DBMET02673 | |
| 0.084 | 0.137 | 0.205 | Cell adhesion inhibitor | 0.189 0.028 DBMET02669 0.205 0.023 DBMET02670 0.203 0.024 DBMET02672 0.188 0.028 DBMET02674 0.192 0.027 DBMET02675 0.152 0.045 DBMET02677 0.174 0.033 DBMET02678 | DBMET02670 | |
| 0.016 | 0.069 | 0.028 | Vanilloid 2 agonist | 0.026 0.017 DBMET02670 0.027 0.015 DBMET02672 0.028 0.012 DBMET02675 | DBMET02675 | |
| 0.081 | 0.135 | 0.118 | Photosensitizer | 0.098 0.092 DBMET02669 0.103 0.082 DBMET02670 0.118 0.059 DBMET02672 | DBMET02672 | |
| 0.061 | 0.116 | 0.087 | Urease inhibitor | 0.087 0.082 DBMET02673 | DBMET02673 | |
| 0.057 | 0.113 | 0.118 | Cell adhesion molecule inhibitor | 0.117 0.025 DBMET02669 0.118 0.024 DBMET02670 0.116 0.025 DBMET02672 0.115 0.026 DBMET02674 0.112 0.027 DBMET02675 0.088 0.044 DBMET02677 0.103 0.033 DBMET02678 | DBMET02670 | |
| 0.106 | 0.165 | 0.287 | Nitric oxide antagonist | 0.253 0.051 DBMET02669 0.26 0.049 DBMET02670 0.28 0.044 DBMET02672 0.273 0.046 DBMET02674 0.287 0.043 DBMET02675 0.259 0.049 DBMET02677 0.279 0.045 DBMET02678 | DBMET02675 | |
| 0.109 | 0.176 | 0.147 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.147 0.077 DBMET02676 | DBMET02676 | |
| 0.075 | 0.15 | 0.109 | Alpha-N-acetylglucosaminidase inhibitor | 0.109 0.089 DBMET02669 0.109 0.089 DBMET02670 | DBMET02670 | |
| 0.015 | 0.091 | 0.039 | Catechol O-methyltransferase inhibitor | 0.039 0.015 DBMET02673 0.033 0.022 DBMET02676 | DBMET02673 | |
| 0.094 | 0.172 | 0.133 | Heat shock protein 90 antagonist | 0.133 0.093 DBMET02676 | DBMET02676 | |
| 0.085 | 0.163 | 0.17 | Protein kinase stimulant | 0.155 0.065 DBMET02670 0.167 0.057 DBMET02672 0.148 0.069 DBMET02675 0.159 0.062 DBMET02677 0.17 0.055 DBMET02678 | DBMET02678 | |
| 0.02 | 0.098 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET02676 0.061 0.02 DBMET02677 0.064 0.018 DBMET02678 | DBMET02676 | |
| 0.124 | 0.209 | 0.371 | Cyclic AMP phosphodiesterase inhibitor | 0.258 0.06 DBMET02670 0.211 0.086 DBMET02672 0.244 0.066 DBMET02675 0.184 0.107 DBMET02676 0.371 0.021 DBMET02677 0.368 0.022 DBMET02678 | DBMET02677 | |
| 0.076 | 0.16 | 0.229 | Lipid peroxidase inhibitor | 0.176 0.052 DBMET02669 0.178 0.051 DBMET02670 0.13 0.083 DBMET02673 0.209 0.038 DBMET02672 0.216 0.035 DBMET02674 0.225 0.033 DBMET02675 0.21 0.038 DBMET02677 0.229 0.032 DBMET02678 | DBMET02678 | |
| 0.064 | 0.159 | 0.188 | Alkylator | 0.178 0.034 DBMET02669 0.147 0.048 DBMET02670 0.15 0.047 DBMET02672 0.188 0.03 DBMET02674 0.151 0.046 DBMET02675 | DBMET02674 | |
| 0.009 | 0.106 | 0.029 | Dopamine D1 agonist | 0.028 0.01 DBMET02676 0.026 0.012 DBMET02677 0.029 0.01 DBMET02678 | DBMET02678 | |
| 0.099 | 0.196 | 0.326 | Hepatoprotectant | 0.303 0.029 DBMET02669 0.311 0.027 DBMET02670 0.319 0.025 DBMET02672 0.319 0.025 DBMET02674 0.326 0.023 DBMET02675 0.312 0.026 DBMET02677 0.326 0.023 DBMET02678 | DBMET02678 | |
| 0.039 | 0.136 | 0.065 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DBMET02669 0.053 0.047 DBMET02670 0.054 0.043 DBMET02672 0.065 0.021 DBMET02674 0.054 0.043 DBMET02675 0.052 0.048 DBMET02678 | DBMET02674 | |
| 0.035 | 0.137 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET02670 0.072 0.058 DBMET02672 0.07 0.06 DBMET02675 | DBMET02672 | |
| 0.023 | 0.125 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.071 0.024 DBMET02669 0.078 0.02 DBMET02670 0.078 0.02 DBMET02672 0.069 0.025 DBMET02674 0.075 0.021 DBMET02675 0.07 0.024 DBMET02677 0.071 0.024 DBMET02678 | DBMET02672 | |
| 0.053 | 0.156 | 0.12 | Creatine kinase inhibitor | 0.12 0.041 DBMET02676 | DBMET02676 | |
| 0.107 | 0.211 | 0.139 | CC chemokine 6 receptor antagonist | 0.135 0.052 DBMET02669 0.132 0.064 DBMET02670 0.135 0.053 DBMET02672 0.135 0.053 DBMET02674 0.136 0.05 DBMET02675 0.139 0.042 DBMET02677 0.133 0.058 DBMET02678 | DBMET02677 | |
| 0.027 | 0.134 | 0.063 | Phosphofructokinase-1 inhibitor | 0.063 0.054 DBMET02669 | DBMET02669 | |
| 0.06 | 0.169 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.065 DBMET02676 | DBMET02676 | |
| 0.08 | 0.197 | 0.226 | Cell wall synthesis inhibitor | 0.154 0.062 DBMET02669 0.204 0.028 DBMET02670 0.222 0.022 DBMET02672 0.167 0.05 DBMET02674 0.2 0.03 DBMET02675 0.212 0.026 DBMET02677 0.226 0.021 DBMET02678 | DBMET02678 | |
| 0.087 | 0.205 | 0.194 | Insulin secretagoues | 0.16 0.065 DBMET02669 0.194 0.039 DBMET02670 0.188 0.043 DBMET02672 0.168 0.058 DBMET02674 0.181 0.047 DBMET02675 0.137 0.088 DBMET02677 0.156 0.068 DBMET02678 | DBMET02670 | |
| 0.15 | 0.271 | 0.212 | 15-Lipoxygenase inhibitor | 0.212 0.2 DBMET02673 | DBMET02673 | |
| 0.026 | 0.148 | 0.059 | Nitric oxide donor | 0.057 0.054 DBMET02672 0.059 0.05 DBMET02675 | DBMET02675 | |
| 0.096 | 0.219 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | 0.122 0.12 DBMET02676 | DBMET02676 | |
| 0.049 | 0.178 | 0.112 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 DBMET02669 0.1 0.039 DBMET02670 0.082 0.073 DBMET02673 0.101 0.038 DBMET02672 0.097 0.044 DBMET02674 0.112 0.026 DBMET02675 0.1 0.04 DBMET02677 0.094 0.049 DBMET02678 | DBMET02675 | |
| 0.102 | 0.234 | 0.149 | Succinate dehydrogenase inhibitor | 0.149 0.115 DBMET02676 | DBMET02676 | |
| 0.054 | 0.188 | 0.111 | Transcription factor NF kappa B stimulant | 0.105 0.035 DBMET02669 0.106 0.034 DBMET02670 0.107 0.033 DBMET02672 0.106 0.034 DBMET02674 0.111 0.03 DBMET02675 0.096 0.042 DBMET02677 0.092 0.048 DBMET02678 | DBMET02675 | |
| 0.074 | 0.216 | 0.158 | Diuretic | 0.129 0.095 DBMET02670 0.147 0.08 DBMET02672 0.138 0.087 DBMET02677 0.158 0.071 DBMET02678 | DBMET02678 | |
| 0.112 | 0.261 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.11 DBMET02678 | DBMET02678 | |
| 0.021 | 0.17 | 0.117 | Antineoplastic antibiotic | 0.113 0.041 DBMET02669 0.105 0.044 DBMET02670 0.111 0.042 DBMET02672 0.117 0.039 DBMET02674 0.114 0.04 DBMET02675 0.11 0.042 DBMET02677 0.117 0.039 DBMET02678 | DBMET02678 | |
| 0.06 | 0.214 | 0.079 | T cell inhibitor | 0.079 0.071 DBMET02670 0.079 0.07 DBMET02672 | DBMET02672 | |
| 0.084 | 0.245 | 0.158 | Interleukin 6 antagonist | 0.131 0.123 DBMET02670 0.158 0.078 DBMET02672 0.143 0.1 DBMET02677 0.157 0.079 DBMET02678 | DBMET02672 | |
| 0.117 | 0.284 | 0.275 | DNA synthesis inhibitor | 0.213 0.104 DBMET02669 0.223 0.091 DBMET02670 0.229 0.084 DBMET02672 0.193 0.135 DBMET02674 0.216 0.099 DBMET02675 0.275 0.053 DBMET02677 0.248 0.068 DBMET02678 | DBMET02677 | |
| 0.136 | 0.31 | 0.344 | Apoptosis antagonist | 0.314 0.076 DBMET02669 0.311 0.078 DBMET02670 0.325 0.07 DBMET02672 0.339 0.061 DBMET02674 0.344 0.059 DBMET02675 0.344 0.059 DBMET02677 0.328 0.068 DBMET02678 | DBMET02677 | |
| 0.017 | 0.192 | 0.06 | HIV-1 integrase (Strand Transfer) inhibitor | 0.06 0.041 DBMET02676 | DBMET02676 | |
| 0.008 | 0.194 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 DBMET02670 0.027 0.016 DBMET02672 0.026 0.016 DBMET02677 0.025 0.019 DBMET02678 | DBMET02670 | |
| 0.119 | 0.305 | 0.358 | Immunomodulator | 0.358 0.057 DBMET02669 0.322 0.071 DBMET02670 0.328 0.068 DBMET02672 0.338 0.064 DBMET02674 0.303 0.081 DBMET02675 0.268 0.102 DBMET02677 0.237 0.126 DBMET02678 | DBMET02669 | |
| 0.024 | 0.211 | 0.064 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET02669 0.056 0.029 DBMET02670 0.061 0.023 DBMET02672 0.056 0.029 DBMET02674 0.061 0.023 DBMET02675 0.061 0.023 DBMET02677 0.064 0.02 DBMET02678 | DBMET02678 | |
| 0.015 | 0.209 | 0.027 | Toll-Like receptor 4 agonist | 0.026 0.019 DBMET02669 0.027 0.017 DBMET02670 0.026 0.019 DBMET02672 0.025 0.022 DBMET02674 0.026 0.021 DBMET02675 | DBMET02670 | |
| 0.044 | 0.253 | 0.086 | NADH dehydrogenase inhibitor | 0.086 0.064 DBMET02669 | DBMET02669 | |
| 0.006 | 0.217 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 DBMET02670 0.025 0.022 DBMET02672 | DBMET02672 | |
| 0.03 | 0.242 | 0.185 | HIV-1 integrase inhibitor | 0.185 0.005 DBMET02676 0.115 0.018 DBMET02677 0.114 0.018 DBMET02678 | DBMET02676 | |
| 0.024 | 0.239 | 0.093 | Topoisomerase II alpha inhibitor | 0.071 0.061 DBMET02670 0.078 0.054 DBMET02672 0.082 0.052 DBMET02674 0.09 0.046 DBMET02675 0.093 0.044 DBMET02677 0.082 0.052 DBMET02678 | DBMET02677 | |
| 0.069 | 0.29 | 0.304 | DNA methylase inhibitor | 0.151 0.116 DBMET02669 0.137 0.129 DBMET02672 0.203 0.077 DBMET02674 0.225 0.063 DBMET02675 0.135 0.132 DBMET02676 0.304 0.027 DBMET02677 0.251 0.048 DBMET02678 | DBMET02677 | |
| 0.032 | 0.27 | 0.058 | Bcl-xL inhibitor | 0.057 0.052 DBMET02673 0.058 0.047 DBMET02676 | DBMET02676 | |
| 0.007 | 0.247 | 0.026 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.021 DBMET02676 | DBMET02676 | |
| 0.135 | 0.389 | 0.453 | Apoptosis agonist | 0.41 0.109 DBMET02669 0.392 0.118 DBMET02670 0.411 0.109 DBMET02672 0.453 0.09 DBMET02674 0.428 0.101 DBMET02675 0.422 0.104 DBMET02677 0.431 0.1 DBMET02678 | DBMET02674 | |
| 0.062 | 0.319 | 0.296 | Platelet adhesion inhibitor | 0.26 0.046 DBMET02669 0.282 0.039 DBMET02670 0.282 0.04 DBMET02672 0.283 0.039 DBMET02674 0.287 0.038 DBMET02675 0.247 0.05 DBMET02677 0.296 0.035 DBMET02678 | DBMET02678 | |
| 0.077 | 0.335 | 0.176 | DNA damaging | 0.176 0.138 DBMET02674 | DBMET02674 | |
| 0.038 | 0.304 | 0.234 | Amylase inhibitor | 0.151 0.064 DBMET02672 0.117 0.083 DBMET02674 0.178 0.052 DBMET02675 0.234 0.033 DBMET02677 0.183 0.05 DBMET02678 | DBMET02677 | |
| 0.043 | 0.311 | 0.139 | Toll-Like receptor 4 antagonist | 0.128 0.036 DBMET02669 0.117 0.047 DBMET02670 0.122 0.041 DBMET02672 0.133 0.032 DBMET02674 0.122 0.042 DBMET02675 0.139 0.028 DBMET02677 0.137 0.029 DBMET02678 | DBMET02677 | |
| 0.065 | 0.336 | 0.146 | DNA repair enzyme inhibitor | 0.146 0.035 DBMET02669 0.123 0.067 DBMET02670 0.134 0.049 DBMET02672 0.13 0.055 DBMET02674 0.11 0.094 DBMET02675 0.122 0.068 DBMET02677 0.133 0.051 DBMET02678 | DBMET02669 | |
| 0.036 | 0.347 | 0.183 | Mcl-1 antagonist | 0.183 0.065 DBMET02676 | DBMET02676 | |
| 0.013 | 0.368 | 0.084 | DNA gyrase inhibitor | 0.084 0.024 DBMET02669 0.084 0.024 DBMET02674 | DBMET02674 | |
| 0.017 | 0.373 | 0.058 | Heparanase inhibitor | 0.055 0.033 DBMET02669 0.054 0.034 DBMET02670 0.058 0.026 DBMET02672 | DBMET02672 | |
| 0.026 | 0.395 | 0.114 | Uric acid excretion stimulant | 0.083 0.077 DBMET02676 0.112 0.043 DBMET02677 0.114 0.041 DBMET02678 | DBMET02678 | |
| 0.056 | 0.436 | 0.156 | ATPase inhibitor | 0.144 0.112 DBMET02670 0.14 0.12 DBMET02672 0.156 0.091 DBMET02675 | DBMET02675 | |
| 0.088 | 0.471 | 0.251 | Caspase 3 stimulant | 0.251 0.111 DBMET02669 0.238 0.124 DBMET02674 0.189 0.187 DBMET02678 | DBMET02669 | |
| 0.041 | 0.43 | 0.206 | DNA methyltransferase I inhibitor | 0.206 0.066 DBMET02677 0.146 0.109 DBMET02678 | DBMET02677 | |
| 0.045 | 0.436 | 0.376 | Tumour necrosis factor alpha release inhibitor | 0.205 0.104 DBMET02669 0.264 0.068 DBMET02670 0.256 0.072 DBMET02672 0.225 0.089 DBMET02674 0.349 0.038 DBMET02675 0.376 0.031 DBMET02677 0.34 0.041 DBMET02678 | DBMET02677 | |
| 0.023 | 0.426 | 0.095 | AMP-activated protein kinase stimulant | 0.095 0.077 DBMET02672 | DBMET02672 | |
| 0.016 | 0.432 | 0.175 | Topoisomerase I inhibitor | 0.09 0.079 DBMET02672 0.086 0.083 DBMET02674 0.087 0.082 DBMET02675 0.168 0.035 DBMET02677 0.175 0.033 DBMET02678 | DBMET02678 | |
| 0.005 | 0.424 | 0.022 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.022 0.009 DBMET02676 | DBMET02676 | |
| 0.018 | 0.445 | 0.193 | Topoisomerase II inhibitor | 0.1 0.086 DBMET02672 0.104 0.082 DBMET02675 0.099 0.087 DBMET02676 0.193 0.035 DBMET02677 0.188 0.036 DBMET02678 | DBMET02677 | |
| 0.068 | 0.498 | 0.288 | Nootropic | 0.288 0.08 DBMET02676 | DBMET02676 | |
| 0.099 | 0.532 | 0.714 | Antiinflammatory | 0.54 0.072 DBMET02669 0.53 0.076 DBMET02670 0.555 0.067 DBMET02672 0.56 0.065 DBMET02674 0.555 0.066 DBMET02675 0.314 0.203 DBMET02676 0.678 0.035 DBMET02677 0.714 0.028 DBMET02678 | DBMET02678 | |
| 0.025 | 0.465 | 0.11 | Xanthine oxidase inhibitor | 0.11 0.052 DBMET02677 0.092 0.068 DBMET02678 | DBMET02677 | |
| 0.022 | 0.468 | 0.111 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.078 DBMET02677 0.111 0.061 DBMET02678 | DBMET02678 | |
| 0.059 | 0.534 | 0.178 | MAP-kinase-activated kinase 5 inhibitor | 0.178 0.135 DBMET02676 | DBMET02676 | |
| 0.067 | 0.541 | 0.267 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.267 0.091 DBMET02676 | DBMET02676 | |
| 0.042 | 0.534 | 0.214 | NOS3 expression enhancer | 0.125 0.106 DBMET02669 0.147 0.075 DBMET02670 0.139 0.084 DBMET02672 0.143 0.08 DBMET02674 0.137 0.087 DBMET02675 0.179 0.051 DBMET02677 0.214 0.036 DBMET02678 | DBMET02678 | |
| 0.015 | 0.513 | 0.152 | DNA intercalator | 0.102 0.072 DBMET02676 0.15 0.042 DBMET02677 0.152 0.042 DBMET02678 | DBMET02678 | |
| 0.036 | 0.558 | 0.087 | Interleukin 12 antagonist | 0.087 0.08 DBMET02677 | DBMET02677 | |
| 0.018 | 0.54 | 0.102 | Beta glucuronidase inhibitor | 0.102 0.066 DBMET02677 0.09 0.089 DBMET02678 | DBMET02677 | |
| 0.027 | 0.663 | 0.129 | Hexokinase inhibitor | 0.129 0.105 DBMET02677 | DBMET02677 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |